Changing Thought and Action in Tobacco Dependence With Transcranial Magnetic Stimulation (rTMS)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- University of Arkansas for Medical Sciences
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 19-55
- Must speak English
- Must be right handed
- Must pass the Transcranial Magnetic Stimulation Adult Safety and Screening Questionnaire (TAAS)
- Smoking participants must be highly dependent with a score of 6 or greater on the Fagerstrom Test for Nicotine Dependence
Exclusion Criteria:
- Positive test for drugs of abuse
- Positive pregnancy test
- A personal or family history of epilepsy
- A history of anticonvulsant medication use
- A personal history of head injury
- A history of aneurysm, stroke, or previous cranial neurosurgery
- A diagnosis of bipolar disorder
- A neurological or psychiatric disorder for which hospitalization was required
- Tinnitus
- Metal implants in the head, neck or cochlea
- A pacemaker
- Migraines
- A history of taking medications that lower seizure threshold (i.e. such as tricyclic antidepressants or bupropion)
- Claustrophobia (due to the MRI)
- Used any form of tobacco in the past two years if they desire to be a non-smoking participant
- Plans to quit smoking in the next 30 days if they desire to be a smoking participant
- Current use of any medications for tobacco cessation (i.e. nicotine replacement, bupropion, varenicline, etc.)
- A report of a high motivation to quit smoking (score 7 or great on the Motivation scale)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Smokers
Healthy adult smokers aged 19-55 who are not currently interested in quitting smoking.
|
All participants will receive 90 10-pulse trains of 1 sec duration with an interval of 20 seconds.
Smokers will receive the treatment twice, once in a nicotine-satiated condition, and once in a nicotine-withdrawal condition.
Other Names:
All participants will receive 45 20-pulse trains of 1 second duration with an interval of 20 seconds.
Smokers will receive the treatment twice, once in a nicotine-satiated condition, and once in a nicotine-withdrawal condition.
Other Names:
The look and sound of active rTMS is reproduced with the same coil used in the active conditions.
The magnetic field in the sham coil is markedly attenuated at only 5% of stimulator output.
The feel of active stimulation will be reproduced by delivering monophasic current pulses to the left, frontalis muscle with a Isolated Stimulator and two carbon rubber electrodes.
Smokers will receive Sham rTMS in both the nicotine-satiated and nicotine-withdrawal conditions.
Other Names:
|
|
Experimental: Non-smokers
Healthy adult non-smokers aged 19-55
|
All participants will receive 90 10-pulse trains of 1 sec duration with an interval of 20 seconds.
Smokers will receive the treatment twice, once in a nicotine-satiated condition, and once in a nicotine-withdrawal condition.
Other Names:
All participants will receive 45 20-pulse trains of 1 second duration with an interval of 20 seconds.
Smokers will receive the treatment twice, once in a nicotine-satiated condition, and once in a nicotine-withdrawal condition.
Other Names:
The look and sound of active rTMS is reproduced with the same coil used in the active conditions.
The magnetic field in the sham coil is markedly attenuated at only 5% of stimulator output.
The feel of active stimulation will be reproduced by delivering monophasic current pulses to the left, frontalis muscle with a Isolated Stimulator and two carbon rubber electrodes.
Smokers will receive Sham rTMS in both the nicotine-satiated and nicotine-withdrawal conditions.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
A Difference Score for the Log Value of K.
Time Frame: baseline and immediately after stimulation, an average of 25 seconds.
|
K is a output value, a summary statistic, derived from a hyperbolic function that summarizes the rate at which monetary values are discounted according to the time they are received.
The value of K can either increase or decrease from its baseline value.
For example, an increase in K would indicate that the participant is choosing to receive larger amounts of money at a later point in time.
A decrease would suggest the opposite - lesser amounts of money at an earlier point in time).
The difference score is calculated from baseline to that immediately after 10 or 20 Hz rTMS.
|
baseline and immediately after stimulation, an average of 25 seconds.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Christine E Sheffer, PhD, University of Arkansas
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 110881
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.